Inventor · disambiguated record
Hu Ge
Also filed as: GE HU
9 granted patents·11 pending applications·6 citations·filing 2018–2025
80Inventor score
Files withJIANGSU HENGRUI MEDICINE CO14HAINAN SIMCERE PHARMACEUTICAL CO LTD3SIMCERE ZAIMING PHARMACEUTICAL CO LTD2SHANDONG SIMCERE BIOPHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
20 records- 0192US12202891B2Antibody capable of binding to thymic stromal lymphopoietin and use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2024·Granted Jan 21, 2025·2 cites·9 claims
- 0290US12258394B2IL-5 antibody, antigen binding fragment thereof, and medical application thereforJIANGSU HENGRUI MEDICINE CO·Filed 2022·Granted Mar 25, 2025·1 cites·13 claims
- 0381US12428478B2Anti-Claudin 18.2 antibody and application thereofJIANGSU HENGRUI MEDICINE CO·Filed 2020·Granted Sep 30, 2025·1 cites·17 claims
- 0478US11365247B2IL-5 antibody, antigen binding fragment thereof, and medical application thereforJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Jun 21, 2022·1 cites·12 claims
- 0577US12319725B2IL-2 mutant and application thereofHAINAN SIMCERE PHARMACEUTICAL CO LTD·Filed 2024·Granted Jun 3, 2025·0 cites·16 claims
- 0675US2025382343A1Il-2 Mutants And Uses ThereofHAINAN SIMCERE PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 0773US12258405B2CD3 antibody and pharmaceutical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted Mar 25, 2025·1 cites·14 claims
- 0872US2024209051A1Il-2 Mutant And Application ThereofHAINAN SIMCERE PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0968US2025333494A1Il-5 antibody, antigen binding fragment thereof, and medical application thereforJIANGSU HENGRUI MEDICINE CO·Filed 2025·Application pending·0 cites
- 1066US12404323B2Antibody capable of binding to thymic stromal lymphopoietin and use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2020·Granted Sep 2, 2025·0 cites·9 claims
- 1165US12421286B2Il-2 mutant and application thereofSHANDONG SIMCERE BIOPHARMACEUTICAL CO LTD·Filed 2021·Granted Sep 23, 2025·0 cites·14 claims
- 1254US2022056094A1Human interleukin-2 variant or derivative thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Application pending·0 cites
- 1352US2023406922A1Humanized cd19 antibody and use thereofSIMCERE ZAIMING PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1451US2023013784A1Anti-cea antibody and application thereofJIANGSU HENGRUI MEDICINE CO·Filed 2020·Application pending·0 cites
- 1550US12428482B2Anti-PD-1 antibody, antigen-binding fragment thereof and pharmaceutical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2020·Granted Sep 30, 2025·0 cites·19 claims
- 1648US2022324953A1Anti-connective tissue growth factor antibody and application thereofJIANGSU HENGRUI MEDICINE CO·Filed 2020·Application pending·0 cites
- 1747US2023012428A1Bifunctional fusion protein and pharmaceutical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2020·Application pending·0 cites
- 1846US2022185875A1Bispecific antibody specifically bound to vegf and ang2JIANGSU HENGRUI MEDICINE CO·Filed 2020·Application pending·0 cites
- 1942US2024301085A1Humanized gpc3 antibody and application thereofSIMCERE ZAIMING PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2042US2020369774A1Il-6r antibody and antigen binding fragment thereof and medical useJIANGSU HENGRUI MEDICINE CO·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hu Ge files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →